Leathers, James S; Balderramo, Domingo; Prieto, John; Diehl, Fernando; Gonzalez-ballerga, Esteban; Ferreiro, Melina R; Carrera, Enrique; Barreyro, Fernando; Diaz-ferrer, Javier; Carrilho, Flair José 
Source: Journal of clinical gastroenterology. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, PROTEÍNAS QUINASES, NEOPLASIAS HEPÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEATHERS, James S et al. Sorafenib for treatment of hepatocellular carcinoma a survival analysis from the south american liver research network. Journal of clinical gastroenterology, v. 53, n. 6, p. 464-469, 2019Tradução . . Disponível em: https://doi.org/10.1097/MCG.0000000000001085. Acesso em: 09 nov. 2024.APA
Leathers, J. S., Balderramo, D., Prieto, J., Diehl, F., Gonzalez-ballerga, E., Ferreiro, M. R., et al. (2019). Sorafenib for treatment of hepatocellular carcinoma a survival analysis from the south american liver research network. Journal of clinical gastroenterology, 53( 6), 464-469. doi:10.1097/MCG.0000000000001085NLM
Leathers JS, Balderramo D, Prieto J, Diehl F, Gonzalez-ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-ferrer J, Carrilho FJ. Sorafenib for treatment of hepatocellular carcinoma a survival analysis from the south american liver research network [Internet]. Journal of clinical gastroenterology. 2019 ; 53( 6): 464-469.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1097/MCG.0000000000001085Vancouver
Leathers JS, Balderramo D, Prieto J, Diehl F, Gonzalez-ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-ferrer J, Carrilho FJ. Sorafenib for treatment of hepatocellular carcinoma a survival analysis from the south american liver research network [Internet]. Journal of clinical gastroenterology. 2019 ; 53( 6): 464-469.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1097/MCG.0000000000001085
